Mapping evidence of mobile health technologies for disease diagnosis and treatment support by health workers in sub-Saharan Africa: a scoping review.
Diagnostic accuracy
Disease diagnosis
Disease screening
Health workers
Mobile health
Sub-Saharan Africa
Therapeutic procedures
Treatment support
mHealth applications
mHealth apps
mHealth technologies
Journal
BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682
Informations de publication
Date de publication:
06 01 2021
06 01 2021
Historique:
received:
21
10
2019
accepted:
22
12
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
24
4
2021
Statut:
epublish
Résumé
The rapid growth of mobile technology has given rise to the development of mobile health (mHealth) applications aimed at treating and preventing a wide range of health conditions. However, evidence on the use of mHealth in high disease burdened settings such as sub-Sharan Africa is not clear. Given this, we systematically mapped evidence on mHealth for disease diagnosis and treatment support by health workers in sub-Saharan Africa. We conducted a scoping review study guided by the Arksey and O'Malley's framework, Levac et al. recommendations, and Joanna Briggs Institute guidelines. We thoroughly searched the following databases: MEDLINE and CINAHL with full text via EBSCOhost; PubMed; Science Direct and Google Scholar for relevant articles from the inception of mHealth technology to April 2020. Two reviewers independently screened abstracts and full-text articles using the eligibility criteria as reference. This study employed the mixed methods appraisal tool version 2018 to assess the methodological quality of the included studies. Out of the 798 articles identified, only 12 published articles presented evidence on the availability and use of mHealth for disease diagnosis and treatment support by health workers in SSA since 2010. Of the 12 studies, four studies were conducted in Kenya; two in Malawi; two in Nigeria; one in South Africa; one in Zimbabwe; one in Mozambique, and one in Lesotho. Out of the 12 studies, one reported the use of mHealth for diseases diagnosis; three reported the use of mHealth to manage HIV; two on the management of HIV/TB; two on the treatment of malaria; one each on the management of hypertension; cervical cancer; and three were not specific on any disease condition. All the 12 included studies underwent methodological quality appraisal with a scored between 70 and 100%. The study shows that there is limited research on the availability and use of mHealth by health workers for disease diagnosis and treatment support in sub-Saharan Africa. We, therefore, recommend primary studies focusing on the use of mHealth by health workers for disease diagnosis and treatment support in sub-Saharan Africa.
Sections du résumé
BACKGROUND
The rapid growth of mobile technology has given rise to the development of mobile health (mHealth) applications aimed at treating and preventing a wide range of health conditions. However, evidence on the use of mHealth in high disease burdened settings such as sub-Sharan Africa is not clear. Given this, we systematically mapped evidence on mHealth for disease diagnosis and treatment support by health workers in sub-Saharan Africa.
METHODS
We conducted a scoping review study guided by the Arksey and O'Malley's framework, Levac et al. recommendations, and Joanna Briggs Institute guidelines. We thoroughly searched the following databases: MEDLINE and CINAHL with full text via EBSCOhost; PubMed; Science Direct and Google Scholar for relevant articles from the inception of mHealth technology to April 2020. Two reviewers independently screened abstracts and full-text articles using the eligibility criteria as reference. This study employed the mixed methods appraisal tool version 2018 to assess the methodological quality of the included studies.
RESULTS
Out of the 798 articles identified, only 12 published articles presented evidence on the availability and use of mHealth for disease diagnosis and treatment support by health workers in SSA since 2010. Of the 12 studies, four studies were conducted in Kenya; two in Malawi; two in Nigeria; one in South Africa; one in Zimbabwe; one in Mozambique, and one in Lesotho. Out of the 12 studies, one reported the use of mHealth for diseases diagnosis; three reported the use of mHealth to manage HIV; two on the management of HIV/TB; two on the treatment of malaria; one each on the management of hypertension; cervical cancer; and three were not specific on any disease condition. All the 12 included studies underwent methodological quality appraisal with a scored between 70 and 100%.
CONCLUSIONS
The study shows that there is limited research on the availability and use of mHealth by health workers for disease diagnosis and treatment support in sub-Saharan Africa. We, therefore, recommend primary studies focusing on the use of mHealth by health workers for disease diagnosis and treatment support in sub-Saharan Africa.
Identifiants
pubmed: 33407438
doi: 10.1186/s12911-020-01381-x
pii: 10.1186/s12911-020-01381-x
pmc: PMC7789784
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
11Références
Heliyon. 2019 Feb 19;5(2):e01236
pubmed: 30828664
Stud Health Technol Inform. 2015;210:316-20
pubmed: 25991157
J Clin Tuberc Other Mycobact Dis. 2019 Jun 06;16:100108
pubmed: 31720432
Global Health. 2006 May 23;2:9
pubmed: 16719925
PLoS One. 2017 Apr 18;12(4):e0176051
pubmed: 28419149
J Med Toxicol. 2010 Jun;6(2):212-6
pubmed: 20623215
Trials. 2017 Oct 11;18(1):475
pubmed: 29020976
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
BMC Med Inform Decis Mak. 2019 May 10;19(1):97
pubmed: 31077222
Int J Clin Pract. 2015 Jan;69(1):9-32
pubmed: 25472682
Lancet. 2010 Nov 27;376(9755):1838-45
pubmed: 21071074
Res Synth Methods. 2014 Dec;5(4):371-85
pubmed: 26052958
Am Heart J. 2019 May;211:22-33
pubmed: 30831331
BMC Public Health. 2013 Dec 05;13:1131
pubmed: 24308409
J Biomed Inform. 2012 Feb;45(1):184-98
pubmed: 21925288
J Acquir Immune Defic Syndr. 2017 Jan 01;74 Suppl 1:S37-S43
pubmed: 27930610
BMC Womens Health. 2019 Jan 7;19(1):2
pubmed: 30616579
Telemed J E Health. 2009 Apr;15(3):231-40
pubmed: 19382860
Niger J Clin Pract. 2019 Jul;22(7):897-905
pubmed: 31293252
Lancet. 2011 Aug 27;378(9793):795-803
pubmed: 21820166
Stud Health Technol Inform. 2015;216:648-52
pubmed: 26262131
Malar J. 2018 Dec 19;17(1):481
pubmed: 30567603
Drug Alcohol Depend. 2018 Sep 1;190:224-228
pubmed: 30056321
JMIR Mhealth Uhealth. 2018 Apr 12;6(4):e87
pubmed: 29650504
BMC Int Health Hum Rights. 2006 Mar 16;6:2
pubmed: 16539744
BMC Health Serv Res. 2018 Dec 4;18(1):934
pubmed: 30514376
Afr J AIDS Res. 2014;13(4):331-8
pubmed: 25555099
PLoS Med. 2012 Feb;9(2):e1001176
pubmed: 22363212
EClinicalMedicine. 2019 Jul 03;13:74-80
pubmed: 31517264
BMJ. 2016 Mar 17;352:i1174
pubmed: 26988021
Springerplus. 2013 Dec;2(1):103
pubmed: 23556144
BMJ Glob Health. 2018 Apr 24;3(Suppl 2):e000722
pubmed: 29713513
BMC Health Serv Res. 2019 Jul 24;19(1):519
pubmed: 31340833
Science. 2014 Sep 12;345(6202):1284-7
pubmed: 25214614
Hypertension. 2018 Aug;72(2):503-510
pubmed: 29967036
Am J Clin Pathol. 2009 Jun;131(6):844-8
pubmed: 19461091
Br J Clin Pharmacol. 2013 Sep;76 Suppl 1:47-55
pubmed: 24007452
Nature. 2019 Feb;566(7745):467-474
pubmed: 30814711
Int J Environ Res Public Health. 2014 Nov 12;11(11):11559-82
pubmed: 25396767